搜索临床试验以:AMN107-尼洛替尼
总计3023个结果
-
National Institute of Allergy and Infectious Diseases...Immune Tolerance Network (ITN)完全的
-
National Cancer Institute (NCI)暂停
-
KeifeRx, LLCWorldwide Clinical Trials; Life Molecular Imaging GmbH; Sun Pharmaceuticals Industries Limited尚未招聘
-
Sheba Medical Center完全的
-
Samsung Medical Center完全的Metastatic Melanoma With KIT Aberration大韩民国
-
Shenzhen Second People's HospitalDongguan People's Hospital; Zhongshan People's Hospital, Guangdong, China; The Affiliated Hospital... 和其他合作者招聘中
-
Andrew J. Wagner, MD, PhDMassachusetts General Hospital; Novartis; Brigham and Women's Hospital主动,不招人
-
Novartis Pharmaceuticals完全的
-
Assistance Publique - Hôpitaux de Paris未知
-
Seoul St. Mary's HospitalNovartis未知
-
Amarin Pharma Inc.完全的心血管疾病美国, 澳大利亚, 加拿大, 印度, 荷兰, 新西兰, 波兰, 罗马尼亚, 俄罗斯联邦, 南非, 乌克兰
-
National Taiwan University Hospital完全的
-
Jill M KolesarNational Cancer Institute (NCI); Novartis招聘中
-
Hospital for Special Surgery, New YorkNovartis Pharmaceuticals; Rudolph Rupert Scleroderma Program完全的
-
Seoul National University HospitalNovartis Pharmaceuticals完全的
-
Indiana UniversityNovartis完全的
-
China Medical University, ChinaGeneral Hospital of Shenyang Military Region; Shengjing Hospital; Liaoning Tumor Hospital & Institute 和其他合作者未知
-
The First Affiliated Hospital of Soochow UniversityAffiliated Hospital of Jiangnan University; Chia Tai Tianqing Pharmaceutical Group Co., Ltd.; Nantong... 和其他合作者未知
-
Shanghai University of Traditional Chinese MedicineShanghai Chest Hospital; Shanghai Pulmonary Hospital, Shanghai, China完全的
-
R.BosLeiden University Medical Center; Galapagos NV; Medical Centre Leeuwarden招聘中
-
Peking Union Medical College Hospital招聘中
-
Sun Yat-sen UniversityChia Tai Tianqing Pharmaceutical Group Co., Ltd.招聘中
-
First People's Hospital of HangzhouChia Tai Tianqing Pharmaceutical Group Co., Ltd.招聘中
-
First People's Hospital of Hangzhou未知
-
Gruppo Italiano Malattie EMatologiche dell'Adulto完全的
-
Novartis Pharmaceuticals批准上市
-
First Hospital of Shijiazhuang City未知
-
University Hospital, Bordeaux完全的白血病,骨髓性,慢性,BCR-ABL 阳性法国
-
Novartis Pharmaceuticals完全的嗜酸性粒细胞增多综合征 | 慢性粒细胞白血病 | 系统性肥大细胞增多症 | 急性淋巴细胞白血病(费城染色体阳性)美国, 波兰, 意大利, 比利时, 加拿大, 法国, 澳大利亚, 荷兰, 瑞典, 瑞士, 英国, 西班牙, 大韩民国, 奥地利, 德国, 丹麦, 芬兰, 新加坡, 台湾, 香港, 新西兰, 挪威
-
Asan Medical Center完全的
-
Novartis Pharmaceuticals终止Philadelphia Positive (Ph+) Chronic Myeloid Leukemia俄罗斯联邦